Stocktoria

ADAPTIN BIO, INC. APTN

OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2026-03-17

ADAPTIN BIO, INC. statistics & valuation

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
202320242025
Return on equity (%)
202320242025
Shares outstanding
5.0M 3.2M 8.7M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-22524.50% -1304.20% -834.60% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
-$0.02 -$0.96 -$0.66 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Return on assets-834.6%-1304.2%-22524.5%
Return on equity347.0%76.2%8.8%
Current ratio0.290.010.00

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.